entertainment
Previous article:
Hepatitis C has a cure — but many Americans still lack access to it
Next article: Readout Newsletter: The latest at Gilead, Catalent, and the NIH
Next article: Readout Newsletter: The latest at Gilead, Catalent, and the NIH
leisure time
leisure time
-
Readout Newsletter: Biogen, Ionis, Johnson & Johnson news
2025-10-02 22:36 -
Obesity drug from Roche shows promise in early study
2025-10-02 22:19 -
CVS is willing to dump 10% of its Medicare Advantage members
2025-10-02 22:13 -
PBM reforms clear House panel
2025-10-02 22:08 -
Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc
2025-10-02 21:11 -
Astellas still sees hope in its gene therapy after four deaths
2025-10-02 20:41